Cardiovascular surgical experiences of IVC tumor and thrombus: Operative strategies Based on 51 consecutive patients

Abstract

Background

The only beneficial treatment option for the management of inferior vena cava (IVC) tumor thrombus is complete tumor removal. The aim of this study was to report our experience in surgical and clinical outcomes in patients with tumor thrombosis in IVC.

Methods

A retrospective chart review of patients who underwent surgical resection of IVC tumor at our institution over the past 10 years was performed. The patients were identified using a prospectively maintained database.

Results

We identified 51 patients, the mean age was 53.4 ± 16.8 years, and 25.4% were female. They were divided into three groups based on tumor thrombosis level. Twenty patients (39.2%) required sternotomy, and cardiopulmonary bypass (CPB) was used in 19 (37.2%) patients, and 2 (3.9%) cases underwent coronary artery bypass graft. The perioperative complications were severe bleeding (3 patients), pulmonary embolism (2 patients), and duodenal perforation (1 patient). Three (5.8%) in-hospital deaths occurred, and all were due to severe abdominal bleeding. After a mean follow-up time of 46.5 ± 42.0 months, 29 (56.9%) patients were alive. The mean survival time was 75.2 ± 8.4 months. In multivariate analysis, higher age (p = 0.033) and male gender (p = 0.033) proved to be independent prognostic factors.

Conclusions

Tumor thrombus extending to the IVC is a rare and challenging event. Although using CPB may be safe and result in long-term survival with acceptable function, excessive bleeding during surgery may limit the use of this method.

Keywords

Cardiopulmonary bypass inferior vena cava renal tumor thrombectomy

Get full access to this article

View all access options for this article.

References

Shi

Kong

, et al. Transitional cell carcinoma with extension of the renal vein and IVC tumor thrombus: report of three cases and literature review. World J Surg Oncol 2016; 14: 309.

Xue

Wang

Xiao

, et al. Functional paraganglioma with tumor thrombus in the inferior vena cava, first case report. Transl Androl Urol 2021; 10: 1813–1820.

Zhang

Huang

Zeng

. Surgery for patients with hepatocellular carcinoma and inferior vena cava tumor thrombus. Sichuan Da Xue Xue Bao Yi Xue Ban 2013; 44: 1005–1008.

Lee

Chung

Kim

, et al. Extrahepatic collateral artery supply to the tumor thrombi of hepatocellular carcinoma invading inferior vena cava: the prevalence and determinant factors. J Vasc Interv Radiol 2009; 20: 22–29.

Reese

Whitson

Meng

. Natural history of untreated renal cell carcinoma with venous tumor thrombus. Urol Oncol 2013; 31: 1305–1309.

Nesbitt

Soltero

Dinney

, et al. Surgical management of renal cell carcinoma with inferior vena cava tumor thrombus. Ann Thorac Surg 1997; 63: 1592–1600.

Neves

Zincke

Taylor

. Metastatic renal cell cancer and radical nephrectomy: identification of prognostic factors and patient survival. J Urol 1988; 139: 1173–1176.

Zini

Haulon

Decoene

, et al. Renal cell carcinoma associated with tumor thrombus in the inferior vena cava: surgical strategies. Ann Vasc Surg 2005; 19: 522–528.

hen

, et al. Treatment of renal cell carcinoma with a level III or level IV inferior vena cava thrombus using cardiopulmonary bypass and deep hypothermic circulatory arrest. World J Surg Oncol 2015; 13: 159.

10.

Ali

Vasdev

Shanmuganathan

, et al. The surgical management and prognosis of renal cell cancer with IVC tumor thrombus: 15-years of experience using a multi-specialty approach at a single UK referral center. Urol Oncol 2013; 31: 1298–1304.

11.

Wang

, et al. Surgery for renal carcinoma with supradiaphragmatic tumor thrombus: avoiding sternotomy and cardiopulmonary bypass. Beijing Da Xue Xue Bao Yi Xue Ban 2016; 48: 729–732.

12.

Ailawadi

Zacour

. Cardiopulmonary bypass/extracorporeal membrane oxygenation/left heart bypass: indications, techniques, and complications. Surg Clin North Am 2009; 89: 781–796.

13.

Issard

Sa Cunha

Fabre

, et al. Surgical resection of tumors invading the inferior vena cava at the hepatic vein and thoracic levels. World J Surg 2021; 45: 3174–3182.

14.

Bower

Nagorney

Cherry

Jr , et al. Replacement of the inferior vena cava for malignancy: an update. J Vasc Surg 2000; 31: 270–281.

15.

Kuehnl

Schmidt

Hornung

, et al. Resection of malignant tumors invading the vena cava: perioperative complications and long-term follow-up. J Vasc Surg 2007; 46: 533–540.

16.

Mihai

Iacobone

Makay

, et al. Outcome of operation in patients with adrenocortical cancer invading the inferior vena cava—A European Society of Endocrine Surgeons (ESES) survey. Langenbecks Arch Surg 2012; 397: 225–231.

17.

Gagné-Loranger

Lacombe

Pouliot

, et al., Renal cell carcinoma with thrombus extending to the hepatic veins or right atrium: operative strategies based on 41 consecutive patients. Eur J Cardiothorac Surg 2016; 50: 317–321.

18.

Boorjian

Sengupta

Blute

. Renal cell carcinoma: vena caval involvement. BJU Int 2007; 99: 1239–1244.

19.

Toren

Abouassaly

Timilshina

, et al. Results of a national population-based study of outcomes of surgery for renal tumors associated with inferior vena cava thrombus. Urology 2013; 82: 572–577.

20.

Niedworok

Dörrenhaus

Dorp

, et al. Renal cell carcinoma and tumour thrombus in the inferior vena cava: clinical outcome of 98 consecutive patients and the prognostic value of preoperative parameters. World J Urol 2015; 10: 1541–1552.